Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

NCT03203473

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes

NCT04929379

Conditions
Autoimmune Diseases, Diabetes Complications, Diabetes Mellitus, +13 more
Locations
  • Joslin Diabetes Center Boston, Massachusetts, United States
  • Lahey Hospital and Medical center Burlington, Massachusetts, United States
  • Brehm Center for Diabetes Research / University of Michigan Ann Arbor, Michigan, United States
  • SUNY Upstate Medical University Syracuse, New York, United States
View Trial Details

Related conditions